Close
Close
Treatment Database
replication defective herpes simplex type 1 virus (HSV-1) vector expressing human COL7 protein
Trade Name not avaiable
Orphan Indication Dystrophic epidermolysis bullosa
USA Market Approval
USA Designation Date 02-11-2017
Sponsor Krystal Biotech, LLC
2100 Wharton Street, Suite 701
Pittsburgh, Pennsylvania, 15203
More about Dystrophic epidermolysis bullosa
Free Newsletter
Related Videos